ストックスクリーナーアプリを入手
0.41
1.01%
0.0041
前日終値:
$0.4059
開ける：
$0.406
24時間の取引高:
180.79K
Relative Volume:
0.12
時価総額：
$5.70M
収益：
$19.57M
当期純損益:
$-25.12M
株価収益率:
-0.1774
EPS:
-2.3114
ネットキャッシュフロー:
$-19.71M
1週間 パフォーマンス:
+4.30%
1か月 パフォーマンス:
-9.79%
6か月 パフォーマンス:
-74.69%
1年 パフォーマンス:
-90.53%
1日の値動き範囲:
$0.3935
$0.4198
1週間の範囲:
$0.3803
$0.4401
52週間の値動き範囲:
$0.3637
$5.6899
Vivos Therapeutics Inc Stock (VVOS) Company Profile
名前
Vivos Therapeutics Inc
セクター
電話
(866)908-4867
住所
7921 SOUTHPARK PLAZA,, LITTLETON
Compare VVOS vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
0.41 | 5.60M | 19.57M | -25.12M | -19.71M | -2.3114 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Vivos Therapeutics Inc (VVOS) 最新ニュース
Vivos Therapeutics Inc (VVOS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Vivos Therapeutics Inc (VVOS) Institutional Confidence - TradingKey
Vivos Therapeutics Inc (VVOS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Vivos Therapeutics Inc (VVOS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
VVOS|Vivos Therapeutics Inc|Price:0.390|Chg%:-0.013 - TradingKey
Vivos Therapeutics, Inc. Revenue Breakdown – NASDAQ:VVOS - TradingView
Vivos Therapeutics Inc (VVOS) Balance Sheet - TradingKey
Vivos Therapeutics Inc (VVOS) Income Statement - TradingKey
Vivos Therapeutics Inc (VVOS) Cash Flow - TradingKey
Vivos Therapeutics Inc (VVOS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
VVOS|Vivos Therapeutics Inc|Price:0.395|Chg%:+0.002 - TradingKey
Vivos Therapeutics Inc (VVOS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
VVOS|Vivos Therapeutics Inc|Price:0.409|Chg%:+0.016 - TradingKey
Vivos Therapeutics Inc (VVOS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Vivos Therapeutics (VVOS) Holds Near Support as Micro-Cap Stock Shows Measured MovementVolatility Breakout Picks - dars.gov.et
Vivos Therapeutics (VVOS) Edges Higher, Testing Key Resistance Near $0.44Dynamic Hedging - dars.gov.et
Vivos Therapeutics (VVOS) Stock Fair Value Falls After Analyst Target Cuts - Yahoo Finance
Vivos Therapeutics (VVOS) Holds Steady at $0.41, Support Level in FocusFear Greed Index - dars.gov.et
Vivos Therapeutics Inc. (VVOS) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Form 4 Vivos Therapeutics Inc For: 15 July By Investing.com - Investing.com Nigeria
Michael C. Skaff Discloses Investment at Vivos Therapeutics with 19.9% Stake - TradingView
Investor group takes 19.9% position in Vivos Therapeutics (VVOS) - Stock Titan
Vivos Therapeutics (NASDAQ: VVOS) insider entity buys 5.5M derivatives - Stock Titan
Vivos Therapeutics (NASDAQ: VVOS) holder discloses warrant and preferred stake - Stock Titan
Price to earnings forward of Vivos Therapeutics, Inc. – NASDAQ:VVOS - TradingView
Vivos Therapeutics (VVOS) Slides 6.87% as Bearish Pressure Tests Critical SupportLate Stage Breakouts - DonanımHaber
A. G. P. Maintains Vivos Therapeutics(VVOS.US) With Hold Rating, Cuts Target Price to $0.75 - Moomoo
Vivos Therapeutics Announces Securities Purchase Agreement and Registration Rights for PIPE Financing - Minichart
Vivos Therapeutics Creates New Series A Preferred Stock - TipRanks
Vivos Therapeutics Raises $2.1 Million in PIPE With V-Co 4 and Bigger Capital - TradingView
Vivos Therapeutics (VVOS) completes $2.1M PIPE with preferred stock and warrants - Stock Titan
Vivos Therapeutics (VVOS) Holds Near Support Amid Modest Decline – Key Levels in FocusMFI Overbought - dars.gov.et
Enterprise value to EBITDA forward of Vivos Therapeutics, Inc. – NASDAQ:VVOS - TradingView
VVOSVivos Therapeutics Inc Latest SEC Filings - Finviz
Vivos Therapeutics (VVOS) Stock Sees Fair Value Moves Lower As Analysts Reset Growth Assumptions - Yahoo Finance
12 Health Care Stocks Moving In Tuesday's After-Market SessionAlzamend Neuro (NASDAQ:ALZN), Vivos Ther - Benzinga
Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants - The Manila Times
Vivos Therapeutics, Inc. announced that it has received $1 million in funding - marketscreener.com
VIVOS THERAPEUTICS INC (VVOS) Stock Chart - ChartMill
Vivos Therapeutics, Inc. Actuals & Estimates (NASDAQ:VVOS) - TradingView
Vivos Therapeutics Extends Debt-for-Equity Conversion Timeline - TipRanks
Vivos (NASDAQ: VVOS) extends Streeterville $4.5M debt-for-equity pact - Stock Titan
Vivos Therapeutics Enters Debt-for-Equity Deal, Extends $2.6M Financing Deadline With Streeterville - TradingView
VVOS Forecast — Price Target — Prediction for 2027 - TradingView
VVOS Q1 2026 Earnings: EPS Misses Estimates as Stock Surges on Operational ProgressOne-Time Gain Impact - Bölüm Sonu Canavarı
Vivos extends debt conversion deadline with Streeterville to August - Investing.com UK
Vivos extends debt conversion deadline with Streeterville to August By Investing.com - Investing.com Australia
Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity - marketscreener.com
Vivos gets more time to convert $4.5M debt into equity - Stock Titan
VVOS Should I Buy - Intellectia AI
Vivos Therapeutics Inc (VVOS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Vivos Therapeutics Inc (VVOS) 財務データ
収益
当期純利益
現金流量
EPS
1.04%
11.95%
大文字化:
|
ボリューム (24 時間):